{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:25:49Z","timestamp":1792099549856,"version":"4.4.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Recurrent vulvovaginal candidosis (RVVC) is a chronic, difficult to treat vaginal infection, caused by <jats:italic>Candida<\/jats:italic> species, which affects women of all ages and ethnic and social background. A long-term prophylactic maintenance regimen with antifungals is often necessary. In most clinical practice guidelines, oral fluconazole is recommended as the first-line treatment. Although clinical resistance to antifungal agents remains rare, overexposure to azoles may increase the development of fluconazole-resistant <jats:italic>C<\/jats:italic>.\u00a0<jats:italic>albicans<\/jats:italic> strains. In addition, <jats:italic>non-albicans Candida species<\/jats:italic> are frequently dose-dependent susceptible or resistant to fluconazole and other azoles, and their prevalence is rising. Available therapeutic options to treat such fluconazole-resistant <jats:italic>C. albicans<\/jats:italic> and low susceptibility non-<jats:italic>albicans<\/jats:italic> strains are limited. Ten experts from different European countries discussed problematic issues of current RVVC diagnosis and treatment in two audiotaped online sessions and two electronic follow-up rounds. A total of 340 statements were transcribed, summarized, and compared with published evidence. The profile of patients with RVVC, their care pathways, current therapeutic needs, and potential value of novel drugs were addressed. Correct diagnosis, right treatment choice, and patient education to obtain adherence to therapy regimens are crucial for successful RVVC treatment. As therapeutic options are limited, innovative strategies are required. Well- tolerated and effective new drugs with an optimized mechanism of action are desirable and are discussed. Research into the impact of RVVC and treatments on health-related quality of life and sex life is also needed.<\/jats:p>","DOI":"10.3389\/fcimb.2022.934353","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T19:21:00Z","timestamp":1662751260000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":81,"title":["Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion"],"prefix":"10.3389","volume":"12","author":[{"given":"Gilbert","family":"Donders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n Oszk\u00e1r","family":"Sziller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Paavonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"de Seta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"Bohbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kotarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi Antoni","family":"Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Cepulien\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Mendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-169","article-title":"Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA","volume":"11","author":"Aball\u00e9a","year":"2013","journal-title":"Health Qual. Life Outcomes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1590\/s0036-46652015000200012","article-title":"Effect of highly active antiretroviral therapy on vaginal candida spp. isolation in HIV-infected compared to HIV-uninfected women","volume":"57","author":"Alczuk Sde","year":"2015","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7042490","article-title":"Prevalence and antifungal susceptibility profile of clinically relevant candida species in postmenopausal women with diabetes","volume":"2020","author":"Al Halteet","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2500\/ar.2015.6.0113","article-title":"Chronic vulvovaginal candida hypersensitivity: An underrecognized and undertreated disorder by allergists","volume":"6","author":"Bernstein","year":"2015","journal-title":"Allergy Rhinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9060312","article-title":"Candidiasis and mechanisms of antifungal resistance","volume":"9","author":"Bhattacharya","year":"2020","journal-title":"Antibiotics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-018-0607-z","article-title":"Vulvovaginal candidiasis: Species distribution of candida and their antifungal susceptibility pattern","volume":"18","author":"Bitew","year":"2018","journal-title":"BMC Women. Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.annepidem.2017.08.010","article-title":"Recurrent vulvovaginal candidiasis","volume":"27","author":"Blostein","year":"2017","journal-title":"Ann. Epidemiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof7020119","article-title":"Immune sensing of candida albicans","volume":"7","author":"Bojang","year":"2021","journal-title":"J. Fungi"},{"key":"B9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.22037\/ijpr.2010.827","article-title":"Effectiveness of fluconazole for suppressive maintenance therapy in patients with RVVC: A randomized placebo-controlled study","volume":"8","author":"Bolouri","year":"2009","journal-title":"Iran. J. Pharm. Res."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02364","article-title":"Targeting the aryl hydrocarbon receptor with indole-3-Aldehyde protects from vulvovaginal candidiasis via the IL-22-IL-18 cross-talk","volume":"10","author":"Borghi","year":"2019","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/TOG.12772","article-title":"Update on recurrent vulvovaginal candidiasis","volume":"23","author":"Borland","year":"2021","journal-title":"Obstet. Gynaecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JCM.01811-20","article-title":"Name changes for fungi of medical importance 2018 To 2019","volume":"59","author":"Borman","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/ajo.13376","article-title":"Evidence-based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis","volume":"61","author":"Bradfield Strydom","year":"2021","journal-title":"Aust. New Zeal. J. Obstet. Gynaecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"624.e1","DOI":"10.1016\/j.ajog.2018.03.001","article-title":"A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis","volume":"218","author":"Brand","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.643639","article-title":"Fungal toxins and host immune responses","volume":"12","author":"Brown","year":"2021","journal-title":"Front. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/cmi.12091","article-title":"Two unlike cousins: Candida albicans and c.glabrata infection strategies","volume":"15","author":"Brunke","year":"2013","journal-title":"Cell. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/21505594.2020.1748930","article-title":"The regulation of hyphae growth in candida albicans","volume":"11","author":"Chen","year":"2020","journal-title":"Virulence"},{"key":"B18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/LGT.0000000000000496","article-title":"Prognosis and long-term outcome of women with idiopathic recurrent vulvovaginal candidiasis caused by candida albicans","volume":"24","author":"Collins","year":"2020","journal-title":"J. Low. Genit. Tract Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD009151.pub2","article-title":"Treatment for recurrent vulvovaginal candidiasis (thrush)","volume":"2022","author":"Cooke","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1471-0528.2008.01830.x","article-title":"Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis","volume":"115","author":"Donders","year":"2008","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"613.e1","DOI":"10.1016\/j.ajog.2008.06.029","article-title":"Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)","volume":"199","author":"Donders","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s10096-020-03868-x","article-title":"The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute candida vaginitis: a proof-of-concept study","volume":"39","author":"Donders","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12811","article-title":"Is non-response to fluconazole maintenance therapy for recurrent candida vaginitis related to sensitization to atopic reactions","volume":"79","author":"Donders","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.diagmicrobio.2018.05.024","article-title":"Is multiple-site colonization with candida spp. related to inadequate response to individualized fluconazole maintenance therapy in women with recurrent candida vulvovaginitis","volume":"92","author":"Donders","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejogrb.2009.04.012","article-title":"Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy","volume":"145","author":"Donders","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1439-0507.2009.01754.x","article-title":"Self-elimination of risk factors for recurrent vaginal candidosis","volume":"54","author":"Donders","year":"2011","journal-title":"Mycoses"},{"key":"B28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1067\/mob.2002.126285","article-title":"Impaired tolerance for glucose in women with recurrent vaginal candidiasis","volume":"187","author":"Donders","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054379","article-title":"Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women","volume":"8","author":"Drell","year":"2013","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jac\/dkl246","article-title":"Probiotics for prevention of recurrent vulvovaginal candidiasis: a review","volume":"58","author":"Falagas","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"38.e1","DOI":"10.1016\/j.ajog.2015.02.002","article-title":"Identification of novel mechanisms involved in generating localized vulvodynia pain","volume":"213","author":"Falsetta","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000371759","article-title":"Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis","volume":"80","author":"Fan","year":"2015","journal-title":"Gynecol. Obstet. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11046-014-9827-4","article-title":"Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis","volume":"179","author":"Fan","year":"2015","journal-title":"Mycopathologia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/myc.13248","article-title":"Guideline: Vulvovaginal candidosis (AWMF 015\/072, level S2k)","volume":"64","author":"Farr","year":"2021","journal-title":"Mycoses"},{"key":"B36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1055\/A-1345-8793","article-title":"Vulvovaginal candidosis (Excluding mucocutaneous candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) society of gynecology and obstetrics (S2k-level, AWMF registry number 015\/072, September 2020)","volume":"81","author":"Farr","year":"2021","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"B37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to c. albicans","volume":"12","author":"Fidel","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/LGT.0b013e3182241f1a","article-title":"Vulvovaginal candidiasis in postmenopausal women: The role of hormone replacement therapy","volume":"15","author":"Fischer","year":"2011","journal-title":"J. Low. Genit. Tract Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/sti.68.6.374","article-title":"The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis","volume":"68","author":"Fong","year":"1992","journal-title":"Sex Transm. Infect."},{"key":"B40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/LGT.0b013e318273e8cf","article-title":"Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the united states: Results from an internet panel survey","volume":"17","author":"Foxman","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00404-019-05228-3","article-title":"Influence of recurrent vulvovaginal candidiasis on quality of life issues","volume":"300","author":"Fukazawa","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00294-018-0867-z","article-title":"Genomes shed light on the secret life of candida glabrata: not so asexual, not so commensal","volume":"65","author":"Gabald\u00f3n","year":"2019","journal-title":"Curr. Genet."},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.642358","article-title":"Ibrexafungerp, a novel oral triterpenoid antifungal in development: Overview of antifungal activity against candida glabrata","volume":"11","author":"Gamal","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/myc.12626","article-title":"Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism","volume":"60","author":"Grinceviciene","year":"2017","journal-title":"Mycoses"},{"key":"B45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1067\/MOB.2001.111938","article-title":"Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis","volume":"184","author":"Guaschino","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/1516-3180.2014.1322640","article-title":"Prevalence of candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women","volume":"132","author":"Gunther","year":"2014","journal-title":"Sao Paulo Med. J."},{"key":"B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/698736","article-title":"Clinical characteristics of Turkish women with candida","volume":"2013","author":"Guzel","year":"2013","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.18502\/cmm.5.4.2062","article-title":"Species distribution and susceptibility profiles of candida species isolated from vulvovaginal candidiasis, emergence of c. lusitaniae","volume":"5","author":"Hashemi","year":"2019","journal-title":"Curr. Med. Mycol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof7080667","article-title":"Candida glabrata: Pathogenicity and resistance mechanisms for adaptation and survival","volume":"7","author":"Hassan","year":"2021","journal-title":"J. Fungi"},{"key":"B50","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/BF01719311","article-title":"Sexual behavior of women with repeated episodes of vulvovaginal candidiasis","volume":"11","author":"Hellberg","year":"1995","journal-title":"Eur. J. Epidemiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1093\/geronb\/gbu105","article-title":"Prevalence of bacterial vaginosis and candida among postmenopausal women in the united states","volume":"69","author":"Hoffmann","year":"2014","journal-title":"J. Gerontol. - Ser. B Psychol. Sci. Soc Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1089\/JWH.2010.2708","article-title":"Boric acid for recurrent vulvovaginal candidiasis: The clinical evidence","volume":"20","author":"Iavazzo","year":"2011","journal-title":"J. Women. Health (Larchmt)"},{"key":"B53","first-page":"1","article-title":"Recurrent vulvovaginal candidosis and cluster analysis of clinical signs and symptoms","volume":"6","author":"Ignjatovic","year":"2020","journal-title":"J. Fungi Artic."},{"key":"B54","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11908-010-0137-9","article-title":"Vulvovaginal candidiasis caused by non-albicans candida species: New insights","volume":"12","author":"Kennedy","year":"2010","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.2017.23.3.139","article-title":"Probiotics in the prevention and treatment of postmenopausal vaginal infections: Review article","volume":"23","author":"Kim","year":"2017","journal-title":"J. Menopausal Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"214","DOI":"10.7883\/yoken.JJID.2019.190","article-title":"Relationship between human \u03b2-defensin 2 and the vaginal environment","volume":"73","author":"Kotani","year":"2020","journal-title":"Jpn. J. Infect. Dis."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.15406\/ogij.2017.07.00260","article-title":"Recurrent vulvo-vaginal candidiasis: Diagnostic and management challenges in a developing country context","volume":"7","author":"Lema","year":"2017","journal-title":"Obstet. Gynecol. Int. J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.m1995","article-title":"Recurrent vulvovaginal candidiasis","volume":"369","author":"Lines","year":"2020","journal-title":"BMJ"},{"key":"B59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bjid.2013.02.001","article-title":"Brazilian Guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade brasileira de infectologia, sociedade paulista de infectologia and sociedade brasileira de medicina tropical","volume":"17","author":"Lopes Colombo","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof4040121","article-title":"An update on the roles of non-albicans candida species in vulvovaginitis","volume":"4","author":"Makanjuola","year":"2018","journal-title":"J. Fungi"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/AOG.0b013e31827307b2","article-title":"Fluconazole-resistant candida albicans vulvovaginitis","volume":"120","author":"Marchaim","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/10647440400003972","article-title":"Usage of antifungal drugs for therapy of genital candida infections, purchased as over-the-counter products or by prescription: 2. factors that may have influenced the marked changes in sales volumes during the 1990s","volume":"12","author":"M\u00e5rdh","year":"2004","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.4236\/ojog.2018.812116","article-title":"Patient preferences in the treatment of vaginal candidiasis","volume":"8","author":"Martens","year":"2018","journal-title":"Open J. Obstet. Gynecol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1086\/322600","article-title":"Prevalence of vaginal colonization by drug-resistant candida species in college-age women with previous exposure to over-the-counter azole antifungals","volume":"33","author":"Mathema","year":"2001","journal-title":"Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc Am."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/myc.13248","article-title":"Guideline: Vulvovaginal candidosis (AWMF 015\/072, level S2k)","volume":"64","author":"McKloud","year":"2021","journal-title":"Mycoses"},{"key":"B66","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1055\/s-0035-1545741","article-title":"Vulvovaginal candidosis (excluding chronic mucocutaneous candidosis). guideline of the German society of gynecology and obstetrics (AWMF registry no. 015\/072, S2k level, December 2013)","volume":"75","author":"Mendling","year":"2015","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13407","article-title":"The interplay between sugar and yeast infections: Do diabetics have a greater predisposition to develop oral and vulvovaginal candidiasis","volume":"13","author":"Mohammed","year":"2021","journal-title":"Cureus"},{"key":"B68","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11046-021-00556-y","article-title":"Difference between the profiles presented by yeasts that colonize the vaginal mucosa or cause primary or recurrent candidiasis","volume":"186","author":"Moreira","year":"2021","journal-title":"Mycopathologia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/817092","article-title":"Clinicoetiological characterization of infectious vaginitis amongst women of reproductive age group from navi Mumbai, India","volume":"2015","author":"Narayankhedkar","year":"2015","journal-title":"J. Sex Transm. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/00002512-200016050-00003","article-title":"Chronic vaginal candidiasis. management in the postmenopausal patient","volume":"16","author":"Nwokolo","year":"2000","journal-title":"Drugs Aging"},{"key":"B71","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1089\/pop.2020.0258","article-title":"Physician awareness and adherence to clinical practice guidelines in the diagnosis of vaginitis patients: A retrospective chart review","volume":"23","author":"Nyirjesy","year":"2020","journal-title":"Popul. Health Manage."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-64705-x","article-title":"Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome","volume":"10","author":"Oerlemans","year":"2020","journal-title":"Sci. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/(SICI)1098-0997(1998)6:4<191::AID-IDOG10>3.0.CO;2-6","article-title":"Boric acid vaginal suppositories: A brief review","volume":"6","author":"Prutting","year":"1998","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02702","article-title":"IL-9 integrates the host-candidacross-talk in vulvovaginal candidiasis to balance inflammation and tolerance","volume":"9","author":"Renga","year":"2018","journal-title":"Front. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1128\/JCM.43.5.2155-2162.2005","article-title":"Antifungal susceptibilities of candida species causing vulvovaginitis and epidemiology of recurrent cases","volume":"43","author":"Richter","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2010.02102.x","article-title":"From saccharomyces cerevisiae to candida glabrata in a few easy steps: Important adaptations for an opportunistic pathogen","volume":"314","author":"Roetzer","year":"2011","journal-title":"FEMS Microbiol. Lett."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms8020144","article-title":"Recurrent vulvovaginal candidiasis: An immunological perspective","volume":"8","author":"Rosati","year":"2020","journal-title":"Microorganisms"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/infdis\/jiz365","article-title":"Vaginal epithelial cells discriminate between yeast and hyphae of candida albicans in women who are colonized or have vaginal candidiasis","volume":"220","author":"Roselletti","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/STI.66.5.357","article-title":"Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet","volume":"66","author":"Roth","year":"1990","journal-title":"Sex Transm. Infect."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1177\/0956462420943034","article-title":"British Association for sexual health and HIV national guideline for the management of vulvovaginal candidiasis (2019)","volume":"31","author":"Saxon","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/DTH.12970","article-title":"Probiotics for oral and vulvovaginal candidiasis: A review","volume":"32","author":"Shenoy","year":"2019","journal-title":"Dermatol. Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"195","DOI":"10.18773\/austprescr.2020.055","article-title":"Treatment of vulvovaginitis","volume":"43","author":"Sheppard","year":"2020","journal-title":"Aust. Prescr."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/0956462418785451","article-title":"2018 European (IUSTI\/WHO) international union against sexually transmitted infections (IUSTI) world health organisation (WHO) guideline on the management of vaginal discharge","volume":"29","author":"Sherrard","year":"2018","journal-title":"Int. J. STD AIDS"},{"key":"B85","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/fampra\/17.2.145","article-title":"Self-medication with vaginal antifungal drugs: Physicians\u2019 experiences and women\u2019s utilization patterns","volume":"17","author":"Sihvo","year":"2000","journal-title":"Fam. Pract."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1086\/343826","article-title":"Vaginitis due to candida krusei: Epidemiology, clinical aspects, and therapy","volume":"35","author":"Singh","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/EVIDoa2100055","article-title":"Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis","volume":"1","author":"Sobel","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2217\/FMB-2021-0173","article-title":"Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis","volume":"16","author":"Sobel","year":"2021","journal-title":"Future Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/14656566.2018.1476490","article-title":"Current treatment options for vulvovaginal candidiasis caused by azole-resistant candida species","volume":"19","author":"Sobel","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"B90","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/nejmoa033114","article-title":"Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis","volume":"351","author":"Sobel","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1128\/IAI.00650-10","article-title":"Regulation of innate immune response to candida albicans infections by \u03b1M\u03b22-Pra1p interaction","volume":"79","author":"Soloviev","year":"2011","journal-title":"Infect. Immun."},{"key":"B92","first-page":"498","article-title":"Recurrent vulvovaginal candidiasis","volume":"5","author":"Sovianti","year":"2021","journal-title":"Biosci. Med. J. Biomed. Transl. Res. Screen Cerv. Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6040267","article-title":"Vulvovaginal candidosis: Current concepts, challenges and perspectives","volume":"6","author":"Sustr","year":"2020","journal-title":"J. Fungi"},{"key":"B94","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1041-2972.2005.0024.x","article-title":"Factors influencing women\u2019s decisions to self-treat vaginal symptoms","volume":"17","author":"Theroux","year":"2005","journal-title":"J. Am. Acad. Nurse Pract."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.617214","article-title":"Combining miconazole and domiphen bromide results in excess of reactive oxygen species and killing of biofilm cells","volume":"8","author":"Tits","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00099","article-title":"Sugar sensing and signaling in candida albicans and candida glabrata","volume":"10","author":"Van Ende","year":"2019","journal-title":"Front. Microbiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/JOF7080664","article-title":"Treating (Recurrent) vulvovaginal candidiasis with medical-grade honey\u2013concepts and practical considerations","volume":"7","author":"Van Riel","year":"2021","journal-title":"J. Fungi"},{"key":"B98","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1701-2163(15)30316-9","article-title":"Vulvovaginitis: Screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis","volume":"37","author":"Van Schalkwyk","year":"2015","journal-title":"J. Obstet. Gynaecol. Canada"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1128\/JCM.02485-07","article-title":"Survey of vaginal-flora candida species isolates from women of different age groups by use of species-specific PCR detection","volume":"46","author":"Vermitsky","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00404-008-0681-9","article-title":"Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of candida species by culture and polymerase chain reaction","volume":"279","author":"Weissenbacher","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"key":"B101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jof6010027","article-title":"Vulvovaginal Candidiasis : A current understanding and burning questions","volume":"6","author":"Willems","year":"2020","journal-title":"J. Fungi"},{"key":"B102","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3238\/arztebl.2020.0126","article-title":"Vulvar pruritus\u2013causes, diagnosis and therapeutic approach","volume":"117","author":"Woelber","year":"2020","journal-title":"Dtsch. Arztebl. Int."},{"key":"B103","volume-title":"Sexually transmitted infections treatment guidelines","author":"Workowski","year":"2021"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010496","article-title":"Probiotics for vulvovaginal candidiasis in non-pregnant women","volume":"11","author":"Xie","year":"2013","journal-title":"Cochrane Database Syst. Rev"},{"key":"B105","doi-asserted-by":"crossref","first-page":"e00684","DOI":"10.1128\/IAI.00684-17","article-title":"Novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: \u201cNeutrophil anergy\u201d","volume":"86","author":"Yano","year":"2018","journal-title":"Infect. Immun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-019-0748-8","article-title":"Current patient perspectives of vulvovaginal candidiasis: Incidence, symptoms, management and post-treatment outcomes","volume":"19","author":"Yano","year":"2019","journal-title":"BMC Women. Health"},{"key":"B107","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.curtheres.2014.07.002","article-title":"Fluconazole resistance patterns in candida species that colonize women with HIV infection","volume":"76","author":"Zhang","year":"2014","journal-title":"Curr. Ther. Res. - Clin. Exp."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.837536","article-title":"Candida albicans multilocus sequence typing clade I contributes to the clinical phenotype of vulvovaginal candidiasis patients","volume":"9","author":"Zhu","year":"2022","journal-title":"Front. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-016-0470-2","article-title":"Health-related quality of life as measured with the short-form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis","volume":"14","author":"Zhu","year":"2016","journal-title":"Health Qual. Life Outcomes"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.934353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T19:21:17Z","timestamp":1662751277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.934353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":109,"alternative-id":["10.3389\/fcimb.2022.934353"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.934353","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"article-number":"934353"}}